Disease often begins before conventional diagnostic thresholds are crossed. Learn to identify earlier changes in hormones, mitochondria, muscle, metabolism, bone, vascular function, sleep, and cognition, and determine what can be objectively measured and changed.

A breast cancer survivor’s perspective on what happens after cancer treatment ends, but endocrine function, muscle, bone, cognition, sexuality, metabolism, and sleep remain profoundly altered.

Examine receptor biology, tumor phenotype, 17β-estradiol, P4 progesterone, synthetic progestins, route, dose, metabolic health, recurrence risk, and the evolving evidence surrounding survivorship.

Integrate ApoB, insulin, lipoproteins, inflammatory markers, hormones, lean mass, visceral fat, bone density, and functional data to build a more complete picture of patient physiology.

Explore potency, absorption, release characteristics, excipients, consistency, and the pharmaceutical execution required for individualized therapy.

Move beyond TSH and follow T3 through nuclear signaling, mitochondrial ATP production, lipid metabolism, cardiac function, brain energy, muscle, gut motility, and peripheral tissue physiology.

Explore Hashimoto thyroiditis, Graves disease, and the gut-immune connection, including dysbiosis, tight-junction disruption, LPS, TLR4, NF-κB, inflammatory signaling, and loss of immune tolerance.

Examine an often-overlooked component of male physiology through allopregnanolone, GABA-A signaling, sleep architecture, autonomic regulation, neurological recovery, and clinical safety.

Connect hormones, mitochondrial energy, cerebral insulin resistance, vascular dysfunction, sleep, APOE4, amyloid, tau, inflammation, and muscle loss to neurocognitive decline before obvious memory loss develops.